“…In current times, the design of many pharmaceutical medicines relies heavily on aroylhydrazones coupled with a heterocyclic moiety. , Isoniazid (isonicotinic acid hydrazide) is a popularly used antituberculosis commercial drug, whereas isoniazid-Schiff bases are found to exhibit preferable anticancer and antitubercular action over isoniazid. , Also, various heterocyclic hydrazones appended with pyridine and quinoline moieties exhibited improved pharmacological activities. , Additionally, it was found that the variable ring sizes and the heteroatoms of the heterocycles in hydrazones also have a significant impact on the selectivities, biomolecular interactions, hydrophobicity, and resulting toxicity profiles of cancer cells. ,, A recent study by our group revealed heterocyclic hydrazones containing dioxidovanadium(V) complexes had favorable hydrophobic properties, biomolecular interactions, and significant anticancer activity . Another important finding of the study was that heterocyclic groups containing systems exhibit increased cytotoxicity with increasing ring size .…”